ARC Clinical Research is enrolling adults ages 50-80 in a study to assess the effectiveness of a blood test in the early detection of lung cancer. An early cancer diagnosis can increase survival rates.
Our team is looking for participants who have an increased risk of lung cancer and are planning to undergo a low-dose CT scan.
About the lung cancer screening study
This clinical study will support the development of an investigational test to detect early stages of lung cancer.
By participating in this study, you would be contributing to the development of groundbreaking technology with the potential to benefit many more people. ARC is one of the many study centers in the United States participating in this research study.
What to expect
The 30-month clinical trial will include in-person visits and phone contact. Participants will be compensated for time and travel.
Who can participate
Adults between the ages of 50 and 80 who are also:
- Planning to undergo a low-dose CT scan of the chest to screen for lung cancer.
- At increased risk of lung cancer. Risk factors include having at least a 20-pack/year smoking history and currently smoking or quitting smoking within the past 15 years.
- Willing to consent to the investigational blood draw.
- Willing to consent to additional follow-up per protocol.
- Additional criteria may apply.
How to enroll in the lung cancer screening clinical study
ARC Clinical Research looks at new ways to prevent, detect, or treat diseases that affect our community. Volunteers in research studies — people just like you — are a critical link in making these discoveries possible.
Learn more about the lung cancer screening clinical study. Call 737-247-7240 to enroll.